Mounjaro Prices: List Cost, Coupons, Compounded Options

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, where GLP-1 pharmacology, weight-management protocols, and the genetic variables underneath them are explained in plain language. Browse the full Peptides & GLP-1 library.

"Mounjaro prices" is a landscape question — people want the whole map, not one number: the list price, why it sits where it does, how coverage swings it, which discounts exist, and how compounded alternatives fit. This breakdown walks the full pricing terrain for tirzepatide as of April 2026, reported as published rather than as any guarantee.

The Mounjaro price landscape

Mounjaro (tirzepatide) is one of the most-searched GLP-1 medications in the U.S. as of April 2026, and the pricing conversation has several moving parts: list price, insurance coverage, manufacturer and pharmacy discounts, and the compounded-pharmacy alternatives that exist alongside the brand. Reading the landscape means understanding how each part pulls on the final number.

List price and what sits behind it

Mounjaro's list price is approximately $1,069 per month at U.S. list as of April 2026, per Eli Lilly's published pricing, and list is rarely what insured patients pay. Behind that figure sits ordinary branded-drug economics: Mounjaro is patent-protected, and Eli Lilly sets list price around R&D cost recovery, market positioning, and expected payer mix. Prices have also stayed high in part because demand outpaced manufacturing in 2023 and 2024.

Coverage variability

Coverage depends on whether the prescription is for an FDA-approved indication and on the specific plan formulary. Many commercial plans cover tirzepatide for type 2 diabetes; coverage for chronic weight management is more variable and often subject to prior authorization or BMI-based criteria. Because plans differ so much, the same drug can carry very different out-of-pocket costs for two people. Check directly with your plan as of April 2026.

Savings programs and discount cards

Eli Lilly publishes a manufacturer savings card that can substantially reduce monthly out-of-pocket cost for eligible commercially-insured patients. Independent pharmacy discount platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy. Eligibility and savings amounts change over time, so verify on the manufacturer website or with your pharmacy at the time of fill.

Compounding and the shortage timeline

Between 2022 and 2024, the FDA listed tirzepatide on its drug shortage list, which opened a regulatory pathway for licensed 503A compounding pharmacies to compound tirzepatide formulations. The FDA resolved the tirzepatide shortage in 2024, narrowing — but not eliminating — that pathway. Legitimate compounded protocols, when prescribed by a licensed clinician through a state-licensed compounding pharmacy, remain a real option, though pricing and access vary widely.

PlexusDx protocol options

PlexusDx offers clinician-supervised compounded GLP-1 protocols inside its Weight Management Protocols — including Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared. See the relevant product page for current pricing as of April 2026.

Genetics as the upstream step

Before any protocol decision, one step sits above the pricing math entirely. Variants in FTO (appetite set-point), GLP1R (the GLP-1 receptor gene), and MC4R (energy balance and satiety) shape your metabolic baseline. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights as trait and pathway education. It never predicts response to a specific medication — it is the test-before-you-invest context PlexusDx brings to every protocol conversation.

The landscape in one view

Step back and the pricing terrain has a shape: a high, patent-driven list price at the top; commercial coverage that may pull it sharply down for the right indication; savings cards and pharmacy coupons that chip away further; and a compounded lane running alongside the whole thing at its own price points. Where you land depends entirely on which of those levers apply to you, which is why no single Mounjaro price ever tells the whole story.

Because every one of those levers can move, the smartest habit is to re-price at the point of fill rather than trusting a figure you saw weeks earlier. Coverage rules, savings terms, and compounding availability all shift, and the number that matters is the one in front of you today.

Frequently Asked Questions

How much does Mounjaro cost without insurance?

List price is approximately $1,069 per month at U.S. list as of April 2026, per Eli Lilly's published pricing. Without insurance and without a manufacturer savings card, that list price is what cash-pay patients face at most U.S. pharmacies. Coupons and compounded alternatives can reduce it.

Why is Mounjaro so expensive?

Mounjaro is a patent-protected branded medication, and Eli Lilly sets list price around R&D cost recovery, market positioning, and expected payer mix. List prices have stayed high in part because demand outpaced manufacturing in 2023 and 2024. Savings programs and compounded alternatives are the main levers patients use.

Is there a coupon or savings card for Mounjaro?

Yes. Eli Lilly publishes a manufacturer savings card that can substantially reduce monthly out-of-pocket cost for eligible commercially-insured patients. Independent pharmacy coupons such as GoodRx and SingleCare publish discounted prices that vary by pharmacy and change frequently. Verify eligibility at the time of fill.

Are compounded versions cheaper?

Often yes. Compounded tirzepatide prepared by licensed 503A pharmacies has historically been priced below Mounjaro list price. The trade-offs are regulatory complexity, variability in prescriber oversight, and the FDA's evolving stance on compounding after the 2024 shortage resolution. Discuss the option with a qualified clinician.

Keep reading inside the PlexusDx Education Hub. Return to the Peptides & GLP-1 library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.